Skip to main content

Table 4 Characteristics of Post COVID-19 headache changes in relation to age, gender COVID-19 severity and baseline Headache frequency and severity

From: Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study

Variables Migraine (post- infection) TTH (post- infection)
N/%
(N = 78)
frequency Analgesic use severity N/%
(N = 11)
frequency Analgesic use severity
Age range:
• ≤40 years 60/76.9 9.19 ± 7.56 3.03 ± 2.14 7.50 ± 2.34 8/72.7 14.26 ± 7.78 3.27 ± 2.28 7.60 ± 1.39
• > 40 years 18/23.1 7.08 ± 7.17 3.08 ± 1.99 7.24 ± 2.31 3/27.3 5.0 ± 2.64 3.06 ± 2.43 3.66 ± 3.05
P   0.224 0.928 0.118   0.063 0.428 0.002*
Gender:
• Male 11/14.1 6.33 ± 6.97 2.42 ± 2.04 5.91 ± 3.05 2/18.2 11.75 ± 7.67 0 5.5 ± 2.08
• Female 67/85.9 8.91 ± 7.18 3.97 ± 2.60 7.67 ± 2.15 9/81.8 13.0 ± 8.30 3.93 ± 2.01 7.49 ± 2.17
P   0.250 0.078 0.016*   0.791 0.002* 0.134
COVID-19 infection severity:
• Mild 68/87.2 8.77 ± 7.38 3.01 ± 2.06 7.50 ± 2.28 10/90.9 12.58 ± 8.18 3.24 ± 2.38 6.94 ± 2.30
• Moderate 10/12.8 7.09 ± 5.57 3.27 ± 2.37 6.90 ± 2.91 1/9.1 15.0 ± 0 0 8.0 ± 0
P   0.472 0.511 0.771   0.778 0.206 0.661
Pre-infection headache frequency
• < 5 days 38/48.7 5.22 ± 4.79 2.48 ± 1.98 7.40 ± 2.35 5/45.5 12.75 ± 8.15 2.63 ± 2.56 7.5 ± 1.6
• ≥5 days 40/51.2 11.51 ± 7.67 3.56 ± 2.07 7.44 ± 2.36 6/54.5 12.7 ± 7.20 3.4 ± 2.41 6.6 ± 2.67
P   < 0.0001* 0.017* 0.935   0.990 0.519 0.415
Pre-infection headache severity
• Mild 8/10.3 5.55 ± 6.12 3.11 ± 2.57 5.88 ± 3.17 2/18.2 10.0 ± 3.55 2.5 ± 2.88 5.75 ± 3.59
• Moderate 30/38.5 10.03 ± 8.03 3.26 ± 2.16 7.0 ± 2.19 8/72.7 12.45 ± 7.36 3.0 ± 2.32 7.18 ± 1.72
• Severe 40/51.2 8.13 ± 6.62 2.89 ± 1.98 8.02 ± 2.13 1/9.1 17.33 ± 14.18 4.0 ± 3.0 8.0 ± 2.0
P   0.22 0.752 0.001*   0.503 0.742 0.411
  1. *=P < 0.05 Paired sample t-test, COVID-19 Coronavirus disease-19, N number, TTH tension type headache